GLP-1 drugs used for type 2 diabetes and obesity are seeing rising demand for weight loss as safety concerns also draw attention. A 2025 WHO guideline said long-term safety data remains limited.
mRNA medicine and spatiotemporal drug delivery systems are expanding options for cardiovascular disease. The sources describe preclinical proof-of-concept, clinical trials and programmable cardiac repair platforms.
Eli Lilly, AbbVie, Vertex, Gilead Sciences and Pfizer were identified as pharmaceutical stocks to watch, with Abbott Laboratories and McKesson appearing on a separate seven-stock list.
Peptris has raised INR 70 crore ($7.7 million) in a Series A round to advance programs toward clinical readiness and expand its AI-led drug discovery pipeline over 24 months.
A new Cochrane review said anti-amyloid Alzheimer’s drugs show no clinically meaningful benefit, but many researchers said the analysis has major limitations. Newer evidence on lecanemab and donanemab and broader drug development efforts continue to shape the field.
A human study found that epoxy-oxylipins help regulate inflammation and that GSK2256294 increased these molecules, reduced pain faster and lowered intermediate monocytes. The findings map epoxy-oxylipin activity in humans during inflammation.
The cell surface markers detection market is projected to grow from $7.01 billion in 2026 to $13.33 billion by 2034, driven by increasing adoption of flow cytometry and applications in immunotherapy research. The market serves pharmaceutical, biotechnology, academic, and clinical research organizations through various workflow stages including sample preparation and cell analysis.
New research reveals that ultra-marathon running damages red blood cells, making them less flexible and accelerating their breakdown. The study found this damage increases with race distance and could potentially lead to anemia. The findings may also help improve blood storage practices for medical transfusions.
The FDA issued a complete response letter rejecting Aldeyra Therapeutics' reproxalap for dry eye disease, marking the third rejection in three years due to inconsistent trial results and lack of substantial evidence of efficacy.
A redesigned CD40 agonist antibody achieved complete remission in two of 12 patients with metastatic cancer in early trials, while separate research identified a method to prevent deadly heart complications from immune checkpoint inhibitors.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07602166 |
Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans |
NOT_YET_RECRUITING | PHASE2 |
| NCT07601841 |
Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function |
RECRUITING | NA |
| NCT07597005 |
Red Propolis Supplementation as a Strategy in Chronic Kidney Disease |
RECRUITING | NA |
| NCT07596992 |
Effects of Royal Jelly and Propolis on Metabolomic Signatures, Inflammation, and Cardiovascular Risk in Patients With Coronary Artery Disease. |
NOT_YET_RECRUITING | NA |
| NCT07596979 |
Ginger in the Modulation of Inflammatory Cytokines and Oxidative Stress in Patients With Coronary Artery Disease |
NOT_YET_RECRUITING | NA |
| NCT07596966 |
EFFECTS OF PROPOLIS AND ROYAL JELLY SUPPLEMENTATION ON INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION |
RECRUITING | NA |
| NCT07596615 |
Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence |
NOT_YET_RECRUITING | NA |
| NCT07580079 |
Anakinra for the Treatment of Postprandial Hypoglycemia in a Patient With Total Gastrectomy and End-Stage Renal Disease |
NOT_YET_RECRUITING | PHASE2 |
| NCT07579845 |
Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress |
NOT_YET_RECRUITING | NA |
| NCT07579182 |
Hormones, Outcomes, and Pain Pathways in Exercise Study |
NOT_YET_RECRUITING | PHASE1 |
